000 | 01967 a2200541 4500 | ||
---|---|---|---|
005 | 20250514072123.0 | ||
264 | 0 | _c20030725 | |
008 | 200307s 0 0 eng d | ||
022 | _a0250-7005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKalas, Wojciech | |
245 | 0 | 0 |
_aFK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand. _h[electronic resource] |
260 |
_bAnticancer research _c |
||
300 |
_a1613-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCalcineurin Inhibitors |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEtoposide _xpharmacology |
650 | 0 | 4 | _aFas Ligand Protein |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aIonomycin _xpharmacology |
650 | 0 | 4 |
_aIonophores _xpharmacology |
650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
650 | 0 | 4 |
_aLymphoma _xpathology |
650 | 0 | 4 |
_aMembrane Glycoproteins _xbiosynthesis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
650 | 0 | 4 | _aNuclear Receptor Subfamily 4, Group A, Member 1 |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aReceptors, Cytoplasmic and Nuclear |
650 | 0 | 4 | _aReceptors, Steroid |
650 | 0 | 4 | _aSulfonamides |
650 | 0 | 4 |
_aTacrolimus _xpharmacology |
650 | 0 | 4 |
_aThymus Neoplasms _xpathology |
650 | 0 | 4 |
_aTranscription Factors _xbiosynthesis |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
650 | 0 | 4 |
_afas Receptor _xbiosynthesis |
700 | 1 | _aMatuszyk, Janusz | |
700 | 1 | _aZiolo, Ewa | |
700 | 1 | _aStrzadala, Leon | |
773 | 0 |
_tAnticancer research _gvol. 23 _gno. 2B _gp. 1613-7 |
|
999 |
_c12603758 _d12603758 |